Ramipril inhibits AGE-RAGE-induced matrix metalloproteinase-2 activation in experimental diabetic nephropathy

被引：0
|
作者：
Kei Fukami
Sho-ichi Yamagishi
Melinda T Coughlan
Brooke E Harcourt
Phillip Kantharidis
Vicki Thallas-Bonke
Seiya Okuda
Mark E Cooper
Josephine M Forbes
机构：
[1] Kurume University School of Medicine,Division of Nephrology, Department of Medicine
[2] Kurume University School of Medicine,Department of Pathophysiology and Therapeutics of Diabetic Vascular Complications
[3] Baker IDI Heart and Diabetes Institute,Diabetes Division
[4] Monash University,Department of Medicine, Central Clinical School
[5] Mater Medical Research Institute,Department of Glycation and Diabetic Complications
来源：
Diabetology & Metabolic Syndrome | / 6卷
关键词：
Advanced glycation end products; Diabetic nephropathy; Renin-angiotensin system; MMP-2; RAGE; NF-κB;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Keratoconus: Matrix metalloproteinase-2 activation and TIMP modulation
    Smith, VA
    Matthews, FJ
    Majid, MA
    Cook, SD
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2006, 1762 (04): : 431 - 439
  • [22] Implication of the activation of matrix metalloproteinase-2 on the metastasis in breast
    Oh, SJ
    Hong, MK
    Kim, KM
    Yoo, SJ
    Jung, SS
    BREAST CANCER RESEARCH AND TREATMENT, 2001, 69 (03) : 316 - 316
  • [23] Elevated matrix metalloproteinase-2 and-9 activities in urine as marker of type 1 diabetic nephropathy
    Diamant, M
    Verheijen, JH
    Hanemaaijer, R
    De Bart, ACW
    Van Der Pluijm, G
    Van Der Bent, C
    Smit, JWA
    Radder, JK
    Lemkes, HHPJ
    DIABETES, 2000, 49 : A154 - A154
  • [24] Influence of homocysteine on matrix metalloproteinase-2:: Activation and activity
    Bescond, A
    Augier, T
    Chareyre, C
    Garçon, D
    Hornebeck, W
    Charpiot, P
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 263 (02) : 498 - 503
  • [25] Elevated matrix metalloproteinase-2 and-9 in urine, but not in serum, are markers of Type 1 diabetic nephropathy
    Diamant, M
    Hanemaaijer, R
    Verheijen, JH
    Smit, JWA
    Radder, JK
    Lemkes, HHPJ
    DIABETIC MEDICINE, 2001, 18 (05) : 423 - 424
  • [26] Anacardic Acid Inhibits the Catalytic Activity of Matrix Metalloproteinase-2 and Matrix Metalloproteinase-9
    Omanakuttan, Athira
    Nambiar, Jyotsna
    Harris, Rodney M.
    Bose, Chinchu
    Pandurangan, Nanjan
    Varghese, Rebu K.
    Kumar, Geetha B.
    Tainer, John A.
    Banerji, Asoke
    Perry, J. Jefferson P.
    Nair, Bipin G.
    MOLECULAR PHARMACOLOGY, 2012, 82 (04) : 614 - 622
  • [27] α-Chaconine Inhibits Angiogenesis in Vitro by Reducing Matrix Metalloproteinase-2
    Lu, Ming-Kun
    Chen, Pei-Hsieng
    Shih, Yuan-Wei
    Chang, Ya-Ting
    Huang, En-Tze
    Liu, Cheng-Ruei
    Chen, Pin-Shern
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2010, 33 (04) : 622 - 630
  • [28] The effect of matrix metalloproteinase-2 for the islets of streptozotocin-induced diabetic mouse model
    Takeshita, A.
    Yasuma, T.
    Nishihama, K.
    Hinneh, J.
    D'Alessandro-Gabazza, C.
    Harada, E.
    Toda, M.
    Yano, Y.
    Gabazza, E.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2016, 46 : 452 - 452
  • [29] Matrix metalloproteinase-2 in the development of diabetic retinopathy and mitochondrial dysfunction
    Mohammad, Ghulam
    Kowluru, Renu A.
    LABORATORY INVESTIGATION, 2010, 90 (09) : 1365 - 1372
  • [30] Carvedilol, a pharmacological antioxidant, inhibits neointimal matrix metalloproteinase-2 and-9 in experimental atherosclerosis
    Wu, Tao-Cheng
    Chen, Yung-Hsiang
    Leu, Hsin-Bang
    Chen, Yuh-Lien
    Lin, Feng-Yen
    Lin, Shing-Jong
    Chen, Jaw-Wen
    FREE RADICAL BIOLOGY AND MEDICINE, 2007, 43 (11) : 1508 - 1522
12345